Oseltamivir Zentiva (Oseltamivir Phosphate)

Oseltamivir phosphate blocks the activity of the influenza virus neuraminidase enzyme. By inhibiting neuraminidase, the drug prevents the release of new viral particles from infected cells, thereby limiting the spread of the virus within the respiratory tract.

The specific dose of Oseltamivir Zentiva is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function and the indication (treatment or prophylaxis). The prescriber will provide the appropriate regimen.

Oseltamivir is classified as pregnancy category B, indicating that animal studies have not shown risk and there are no well‑controlled studies in pregnant women. It may be used during pregnancy when the benefit outweighs any potential risk, and breastfeeding decisions should be made with a physician.

To order Oseltamivir Zentiva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

The primary alternative to Oseltamivir is zanamivir, another neuraminidase inhibitor administered by inhalation. Oseltamivir is taken orally, which may be more convenient for many patients, while zanamivir’s inhaled route can be advantageous for patients with gastrointestinal intolerance to oral agents.

Oseltamivir Zentiva should be stored at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Oseltamivir Zentiva is administered orally, usually as a tablet. It can be taken with or without food, according to the prescriber’s instructions. The medication is swallowed whole with water and not chewed or crushed unless specifically advised.

Serious risks include severe allergic reactions such as rash or anaphylaxis, neuropsychiatric events like delirium or hallucinations, and rare severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if any of these symptoms occur.

Oseltamivir Zentiva should be avoided in individuals with known hypersensitivity to oseltamivir or any component of the formulation. Caution is also advised for patients with severe renal impairment, and the drug should be used only under medical supervision in pregnant or breastfeeding women.